Glaxo stops funding commercial CME; Merck funding $150M non-profit vaccine developer;

> In another sign that drugmakers want to reduce their exposure to payola allegations, GlaxoSmithKline has announced that it will stop funding commercial continuing medical education programs. FiercePharma [1]

> Working with the UK's Wellcome Trust, Merck is funding a $150 million non-profit vaccine developer focused on inexpensive shots for developing countries. FierceVaccines [2]

> Could Hispanics be the next big market for mobile healthcare innovation? Some experts--including former Al Gore spokesman Jonathan Spalter--say there's a big opportunity here to improve this population's health. FierceMobileHealthcare [3]

> A group of UCLA researchers seem to have found a way to make paralyzed rates capable of walking again, using drugs, electrical stimulation and regular exercise. FierceBiotechResearch [4]

And Finally... Hey, buddy, why didn't you just subscribe to Netflix yourself, for heaven's sake? Article [5]